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Eosinophilic Heart Disease: A Case Report and Review of Literature
Ghulam Akbar, MD; Fnu Vikram, MD; Ronald Freudenberger, MD and Matthew Martinez, MD
Department of Cardiovascular Medicine, Lehigh Valley Health Network, Allentown, Pennsylvania

INTRODUCTION
Hypereosinophilic syndrome (HES) is a multisystem disorder
diagnosed by the presence of hypereosinophilia (HE) defined as
an absolute eosinophil count (AEC) >1.5x109/L (or >1500cells/
microL) and multi organ involvement attributable to HE. Myocardial
dysfunction is a frequent finding and is a major cause of morbidity
and mortality in HES. The diagnosis of hypereosinophilic heart
disease (EHD) is made in the setting of hypereosinophilia and
characteristic clinical features and imaging findings of damage to
the heart. We describe those clinical features in this case of HES with
HHD with review of literature.
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CASE
A 63 year old active smoker male with no known past medical history
was transferred to our hospital for hypotension, abnormal EKG and
elevated troponin. The patient described nonspecific symptoms of
cough, runny nose, malaise, muscle aches, nausea, diarrhea and
low grade fever for 2-3 weeks. He also noted a skin rash which had
resolved at the time of admission. He denied air travel outside the
United States.
His examination revealed diminished lung sounds bilaterally, normal
heart sounds with a soft 1/6 intensity holosystolic murmur without
marked radiation of the murmur. There was mild lower extremity
edema present.
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LAB DATA AND IMAGING
Laboratory data revealed hyponatremia, normal creatinine and an
elevated troponin I value of 2.89, WBC count of 15000, Hb of 9 gram/
dl and platelet count of 40,000. His eosinophil count was 4800
(UNITS), LDH 719, 32% Eos.
CT contrast chest abdomen and pelvis revealed no PE or dissection,
marked lymphadenopathy and small pleural effusions only.
His EKG was sinus rhythm with diffuse T wave inversions.
Transthoracic echocardiogram revealed hyperdynamic left ventricular
(LV) systolic function and apical thickening concerning for an LV
thrombus (Figure 1a & 1b).
MRI of the heart confirmed the diagnosis of apical thrombus along
with fibrotic material seen in both LV and RV apex (Figure 2a & 2b).

HES are a heterogeneous group of disorders. Typically symptoms are very
nonspecific as in our case. A rash, GI disturbances, cough and dyspnea are
the common symptoms. Pathophysiology of EHD includes three overlapping
stages: 1) an acute necrosis, 2) thrombosis and 3) fibrosis. The clinical
presentation of EHD is variable and may range from an asymptomatic
myocardial involvement to heart failure syndrome, conduction abnormality,
fatal arrhythmia, sudden cardiac death or an acute coronary like syndrome.
It is important to note that EHD can be seen in any cause of eosinophilia or
hypereosinophilia such as drugs and hypersensitivity reactions, parasitic or
protozoal infections, malignancies, idiopathic hypereosinophilic syndromes
or vasculitis syndromes.
Endomyocardial biopsy is the reference standard test for the definite
diagnosis of EHD. Eosinophilia is present in the majority of the patients.
Electrocardiographic changes are common but nonspecific and may
include criteria for left ventricular hypertrophy, arrhythmias or AV block.

Echocardiography plays a vital role in suspecting and identifying EHD.
Cardiac MRI has higher sensitivity and specificity than any other imaging
modalities. It is important to find the etiology of hypereosinophila and treat
it accordingly. Offending drug needs to be discontinued.
Malignancies and Vasculitis treated accordingly. Steroids have remained
the mainstay of therapy in acute settings
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His axillary lymph node biopsy showed angioimmunoblastic T cell lymphoma. He was readmitted
again for VT and chemotherapy induced pancytopenia.
Required high doses of steroids while inpatient.
His Eosinophil count on discharge was 0% compared
to 32% maximum on first admission.
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